1 – 7 of 7
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
High expression of stromal PDGFRβ is associated with reduced benefit of tamoxifen in breast cancer
(
- Contribution to journal › Article
- 2014
-
Mark
G protein-coupled estrogen receptor in the plasma membrane is prognostic in early breast cancer
(
- Contribution to journal › Published meeting abstract
- 2011
-
Mark
Time dependent effects of adjuvant tamoxifen therapy on cerebrovascular disease: results from a randomised trial
(
- Contribution to journal › Article
- 2003
-
Mark
Risk factors for local recurrence after breast-conserving surgery
(
- Contribution to journal › Article
- 2002
-
Mark
Consequences of axillary recurrence after conservative breast surgery
(
- Contribution to journal › Article
- 1998
-
Mark
Dosage of adjuvant G-CSF (filgrastim)-supported FEC polychemotherapy based on equivalent haematological toxicity in high-risk breast cancer patients. Scandinavian Breast Group, Study SBG 9401
1998) In Annals of oncology : official journal of the European Society for Medical Oncology 9(4). p.403-411(
- Contribution to journal › Article
-
Mark
Multimodality treatment of 128 patients with locally advanced breast carcinoma in the era of mammography screening using standard polychemotherapy with 5-fluorouracil, epirubicin, and cyclophosphamide : prognostic and therapeutic implications
(
- Contribution to journal › Article